Incidence and extent of a systemic inflammatory response in patients after successful cardiopulmonary resuscitation

Organizational Data

DRKS-ID:
DRKS00009684
Recruitment Status:
Recruiting ongoing
Date of registration in DRKS:
2015-11-27
Last update in DRKS:
2017-09-01
Registration type:
Retrospective

Acronym/abbreviation of the study

No Entry

URL of the study

No Entry

Brief summary in lay language

Despite modern intensive care, prognosis of patients suffering cardiac arrest still remains poor. This high mortality can be attributed to the development of the post-cardiac arrest syndrome, which is thought to be mediated by a systemic inflammatory response. In this prospective observational study the incidence and extent of a systemic inflammatory response will be investigated in blood samples from patients after successful cardiopulmonary resuscitation which will be compared to a control group with coronary artery disease without acute myocardial infarction.

Brief summary in scientific language

Despite improvement in modern intensive care, patients after primarily successful resuscitation still have an impaired prognosis. Intrahospital mortality can be attributed to the development of the post-cardiac arrest syndrome, a unique and complex combination of pathophysiological processes which include anoxic brain injury, myocardial dysfunction, systemic ischemia-reperfusion response and the unresolved pathological condition that caused circulatory arrest [2]. It is thought that whole body ischemia and finally the return of spontaneous circulation after successful cardiopulmonary resuscitation results in generation of reactive oxygen species [3] which lead to induction of a systemic inflammatory response [4] with production of proinflammatory cytokines [5] as well as an endothelial damage with microthrombosis [6, 7]. These processes contribute to microcirculatory disorder and capillary leakage, which finally lead to a “sepsis-like” syndrome [5]. In this prospective observational study the incidence and extent of a systemic inflammatory response will be investigated in blood samples from patients after circulatory arrest, which will be compared to a control group with coronary artery disease without acute myocardial infarction. 1. Peberdy MA, Kaye W, Ornato JP, Larkin GL, Nadkarni V, Mancini ME et al. Cardiopulmonary resuscitation of adults in the hospital: a report of 14720 cardiac arrests from the National Registry of Cardiopulmonary Resuscitation. Resuscitation. 2003;58(3):297-308. 2. Neumar RW, Nolan JP, Adrie C, Aibiki M, Berg RA, Bottiger BW et al. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation. 2008;118(23):2452-83. 3. Idris AH, Roberts LJ, 2nd, Caruso L, Showstark M, Layon AJ, Becker LB et al. Oxidant injury occurs rapidly after cardiac arrest, cardiopulmonary resuscitation, and reperfusion. Crit Care Med. 2005;33(9):2043-8. 4. Gando S, Nanzaki S, Morimoto Y, Kobayashi S, Kemmotsu O. Out-of-hospital cardiac arrest increases soluble vascular endothelial adhesion molecules and neutrophil elastase associated with endothelial injury. Intensive care medicine. 2000;26(1):38-44. 5. Adrie C, Adib-Conquy M, Laurent I, Monchi M, Vinsonneau C, Fitting C et al. Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation. 2002;106(5):562-8. 6. Gando S, Nanzaki S, Morimoto Y, Kobayashi S, Kemmotsu O. Alterations of soluble L- and P-selectins during cardiac arrest and CPR. Intensive care medicine. 1999;25(6):588-93. 7. Gando S, Kameue T, Nanzaki S, Nakanishi Y. Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest. Thromb Haemost. 1997;77(2):278-82.

Health condition or problem studied

ICD10:
I46.0 - Cardiac arrest with successful resuscitation
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
Blood samples from patients after cardiac arrest with successful resuscitation
Arm 2:
Blood samples from patients with coronary artery disease without acute myocardial infarction

Endpoints

Primary outcome:
Quantitative analysis of peripheral blood leucocyte subclasses; Expression of markers of antigen presentation; Leucocyte response to activation by stimulatory agents; Leucocyte and whole blood expression of markers of innate immunity inflammatory signaling, including toll-like receptor and inflammasome signaling; Single blood sample from control group; Sequential blood sampling in patients in the first hours after survived cardiac arrest as well as 1 day and 2 days after resuscitation;
Secondary outcome:
/

Study Design

Purpose:
Basic research/physiological study
Retrospective/prospective:
No Entry
Study type:
Non-interventional
Longitudinal/cross-sectional:
No Entry
Study type non-interventional:
No Entry

Recruitment

Recruitment Status:
Recruiting ongoing
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Monocenter study
Recruitment location(s):
  • University medical center Universitätsklinikum Freiburg; Abteilung für Kardiologie und Angiologie I Freiburg im Breisgau

Recruitment period and number of participants

Planned study start date:
No Entry
Actual study start date:
2010-09-21
Planned study completion date:
No Entry
Actual Study Completion Date:
No Entry
Target Sample Size:
100
Final Sample Size:
No Entry

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
Cardiac arrest with successful resuscitation; Coronary artery disease without acute myocardial infarction

Exclusion Criteria

Preexisting acute- or chronic-inflammatory diseases; Preexisting acute- or chronic-infectious diseases; Multiple organ dysfunction syndrome; Immunosuppressive medication

Addresses

Primary Sponsor

Address:
Universitätsklinikum Freiburg / Universitäts-Herzzentrum Freiburg - Bad Krozingen
Hugstetter Str. 55
79106 Freiburg
Germany
Telephone:
004976127034010
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Universitätsklinikum Freiburg / Universitäts-Herzzentrum Freiburg - Bad Krozingen
Dr. Katrin Fink
Hugstetter Str. 55
79106 Freiburg im Breisgau
Germany
Telephone:
004976127034010
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Contact for Public Queries

Address:
Universitätsklinikum Freiburg / Universitäts-Herzzentrum Freiburg - Bad Krozingen
Dr. Katrin Fink
Hugstetter Str. 55
79106 Freiburg im Breisgau
Germany
Telephone:
004976127034010
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Principal Investigator

Address:
Universitätsklinikum Freiburg / Universitäts-Herzzentrum Freiburg - Bad Krozingen
Dr. Katrin Fink
Hugstetter Str. 55
79106 Freiburg im Breisgau
Germany
Telephone:
004976127034010
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Sources of Monetary or Material Support

Institutional budget, no external funding (budget of sponsor/PI)

Address:
Universitätsklinikum Freiburg / Universitäts-Herzzentrum Freiburg - Bad Krozingen
Hugstetter Str. 55
79106 Freiburg
Germany
Telephone:
004976127034010
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Ethics Committee

Address Ethics Committee

Address:
Ethik-Kommission der Albert-Ludwigs-Universität Freiburg
Engelberger Str. 21
79106 Freiburg
Germany
Telephone:
+49-761-27072600
Fax:
+49-761-27072630
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2009-09-01
Ethics committee number:
328/09
Vote of the Ethics Committee:
Approved
Date of the vote:
2009-09-29

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No Entry
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry